Navigation Links
AspenBio Announces Dismissal of Class Action and Chipman Lawsuits by U. S. District Court
Date:9/18/2012

CASTLE ROCK, Colo., Sept. 18, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that the United States District Court for Colorado has dismissed and entered judgment without prejudice in both the class action lawsuit (Case No. 11-cv-00165-REB-KMT) against the company and certain of its former or current officers and directors, and the Mark Chipman lawsuit (Case No. 11-cv-00163-REB-KMT) against the company.

"We are very pleased with the court's decisions," stated Steve Lundy, President and CEO of AspenBio.  "We continue to execute on our priority of advancing AppyScore™ toward commercialization."

About AspenBio Pharma
AspenBio Pharma, Inc. is an in vitro diagnostic company focused on the clinical development and commercialization of its lead product, AppyScore.  AppyScore is a unique blood-based test with projected high sensitivity and negative predictive value that is designed to aid in the identification of patients at low risk for acute appendicitis, allowing for more conservative patient management.  AppyScore is initially being developed for pediatric, adolescent and young adult patients with abdominal pain as this population is at the highest risk for appendicitis as well having the highest risk of the long-term health effects associated with CT imaging.  For more information, visit www.aspenbiopharma.com.

Forward-Looking Statements
This press release includes "forward-looking statements" of AspenBio Pharma, Inc. ("AspenBio") as defined by the Securities and Exchange Commission ("SEC"). All statements, other than statements of historical fact, included in this press release that address activities, events or developments that AspenBio believes or anticipates will or may occur
'/>"/>

SOURCE AspenBio Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Neogen Corporation Announces 1st Quarter Results Conference Call
2. Genomic Health Announces Positive Topline Results of Large Prostate Cancer Clinical Validation Study; Company to Proceed with 2013 Commercial Launch
3. Kymab Announces Launch of Kymouse HK
4. AMRI Announces Strategic Contract with Knopp Biosciences
5. Ceramic Society announces selection of Ichinose, Lawn and Moskowitz as 2012 Distinguish Life Members
6. Islet Sciences Announces Exclusive License Agreement with the University of California (UCLA) to Commercialize Small Molecules for Islet Expansion
7. Sequenom Announces Participation At Two Upcoming Investor Conferences
8. BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference
9. Medical Diagnostic Laboratories, L.L.C. Announces a Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia Trachomatis
10. Pro Bono Bio Announces the Successful Development of Subcutaneous and Long-Acting Blood Factors VIIa,VIII and IX for the Treatment of Haemophilia
11. Islet Sciences Announces Exclusive License Agreement with Winthrop University Hospital to Commercialize a Beta Cell Loss Measurement Technology in Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... SAN MARINO, Calif. , May 23, 2013 ... announces today a strategic alliance with DAK Renewable ... increase the corn oil yield. VG Energy is ... Inc. (OTC Pink: VGLS). VG Energy,s ... pathways to increase the oil yield in plants, ...
(Date:5/23/2013)... 2013 On April 19th the ... to search for the growing antibiotic resistant bacteria that ... a year long study were released late last month ... meats, over previous years. For those suffering from bacteria ... antibiotic resistant bacteria in food, may eventually help breed ...
(Date:5/23/2013)... , May 23, 2013 Pressure BioSciences, ... that the Company will host a teleconference to discuss ... a business update. The teleconference information is provided below: ... a.m. Eastern Daylight Time (EDT) Dial-in: (800) ... (302) 607-2001 (Int,l) Passcode: VS22823 For those ...
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ... only FDA, Health Canada and CE (Europe) approved Total ... in Scotland, which boasts more than 380,000 visitors annually, ... powered by the Freedom® portable driver as part ... most advanced exhibitions of its kind. , “BodyWorks ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
... AstraZeneca Exec to Lead Hong Kong-based subsidiary Pangu BioPharmaSAN ... biopharmaceutical company focused on discovery and development of an ... multiple disease indications, today announced that Dr. James Cai ... Clinical Development at aTyr Pharma and President of Pangu ...
... & Sullivan recognizes BioTrove, Inc. with the 2009 ... Strategy Leadership of the Year. The annual ... most significant drug-discovery innovations and acknowledgments by life ... specializing in drug acceleration and pipeline assessment technologies, ...
... One Corporation (Pink Sheets: MNCN), announced today that its ... serve as the company,s Chief Financial Officer, effective March ... said, "Pat brings a strong background in finance to ... financial expertise will be great assets to Mach One ...
Cached Biology Technology:Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia 2Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia 3Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 2Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 3Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 4Mach One Announces Appointment of Chief Financial Officer 2
(Date:5/23/2013)... and fastest growing open-access publishers, announces the launch ... and Biotechnology . , A broad scope ... and Biotechnology will provide a single open-access ... research to be disseminated and discussed. , ... provide an open-science and interactive web platform for ...
(Date:5/22/2013)... cell powered buses, including a team from Simon ... processes and bus membrane durability. , The team ... in the operating cycle of the bus on ... study, led by SFU graduate student Natalia MaCauley, ... Burnaby-based Ballard Power Systems and funded by Automotive ...
(Date:5/22/2013)... The discovery of potential environmental and human health ... batteries each year has led scientists to recommend ... reuse of lithium-ion (Li-ion) battery materials. That,s the ... journal Environmental Science & Technology . , ... Li-ion batteries have become mainstays for powering everything ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in Bioengineering and Biotechnology 2Tests lead to doubling of fuel cell life 2
... counters prevailing thought, a study in mice has found ... "fat-burning" can actually increase energy expenditure and help lower ... the JBC, might lead to some new ... warm-blooded animals need to continually "burn fat" in order ...
... filling such an important niche in ocean communities that ... however, that sea otters can have even farther-reaching effects ... of another top predator: the bald eagle. ... of 250 feet and function much like trees in ...
... 2008) To help improve the success of oyster ... Center for Environmental Science researcher Dr. Elizabeth North is ... study to determine when oysters spawn and where their ... is supported by a $750,000 competitive grant from the ...
Cached Biology News:Making metabolism more inefficient can reduce obesity 2Decline in Alaskan sea otters affects bald eagles' diet 2Decline in Alaskan sea otters affects bald eagles' diet 3
Rat Hepatocytes (RH) (>3,000,000 cells)...
... of proteomics demands the detection of very ... of the AXIMA-CFRplus with improved resolution (20,000) ... provides increased confidence in protein identification. The ... sensitivity, automated sample target handling and the ...
...
... The new MALDI O-TOF creates a ... on an orthogonal platform that has been ... the University of Manitoba. , As the ... orthogonal design and collisional cooling, the prOTOF ...
Biology Products: